Journals / MN Kardiyoloji / 2002 / Cilt: 9 - Sayı: 2

The effect of coronary artery disease risk factors to development of recurrent in stent restenosis (ISR)

Koroner arter hastalığı risk faktörlerinin rekürren stent içi restenozu gelişimine etkisi

Pages
117–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hereditary risk factors may have a role at the response to the stent implantation and repeated interventions for ISR.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: In this study we analyzed the effect of classical coronary artery disease (CAD) risk factors (gender, smoking, hypertension, diabetes, hyperlipidemia and family history of CAD) on the treatment of ISR with percutaneous transluminal (PTCA) by evaluating the patient clinically and by coronary angiography (CAG) in the late period.
📊
Key Findings & Data:MATERIAL AND METHODS: Fifty-three patients with established ISR (age:59±5 years,male/female:40/13) were evaluated both clinically and by quantitative angiographical data as well just before the PTCA, immediately afterwards and within 6 months or when necessary earlier.
💡
Conclusion & Impact:Hereditary risk factors may have a role at the response to the stent implantation and repeated interventions for ISR.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Koroner anjiyografi · Stentler · Anjiyoplasti

Abstract

AIM: In this study we analyzed the effect of classical coronary artery disease (CAD) risk factors (gender, smoking, hypertension, diabetes, hyperlipidemia and family history of CAD) on the treatment of ISR with percutaneous transluminal (PTCA) by evaluating the patient clinically and by coronary angiography (CAG) in the late period. MATERIAL AND METHODS: Fifty-three patients with established ISR (age:59±5 years,male/female:40/13) were evaluated both clinically and by quantitative angiographical data as well just before the PTCA, immediately afterwards and within 6 months or when necessary earlier. We analyzed the relation between the angiographical and clinical data and presence of CAD risk factors within 6 month's of follow-up. RESULTS: Sixty-eight percent of the smoking patients developed diffuse type recurrent ISR after PTCA (p=0.045). In women minimal luminal diameter and reference segment diameter (RSD) were significantly lower than men only at the control CAG (p=0.008). At the measurement of control KAG, RSD was lower in patients with hyperlipidemia in comparison to non-hyperlipidemic patients (p=0. 050). In patients with family history of CAD ISR recurred earlier (2.57±2.2 months to 5.57±3.5, p=0.05). All the patients showing severe arrhythmia, developing reinfarction, requiring urgent CABG or died of CAD were hypertensive (p=0.026). Three of the 5 patients requiring CABG after PTCA for ISR had DM (p=0.051). Patients with family history of CAD frequently encountered post PTCA MI (p=0.009). CONCLUSION: There was a significant relationship between clinical adverse events during thefollow-up and CAD risk factors like hypertension, family history and diabetes. Smokers usually had diffuse type recurrent ISR. Reference segment was also severly affected in hyperlipidemic and female patients. In patients with family history recurrent stenosis occurred more earlier after PTCA of ISR. According these data patients having family history of CAD showed quite aggressive stenotic response after PTCA of ISR. Hereditary risk factors may have a role at the response to the stent implantation and repeated interventions for ISR.

Özet

AMAÇ: Bu çalışmada stent içi restenozun (SİR) perkütan transluminal balon anjiyoplasti (PTBA) ile tedavisinde klasik kardiyovasküler risk faktörlerinin (cinsiyet, sigara içimi, hipertansiyon (HT), diyabetes mellitus (DM), hiperlipidemi ve ailede koroner arter hastalığı (KAH) öyküsü bulunması), geç dönem klinik ve kantitatif anjiyografik sonuçlarına etkisi araştırıldı. GEREÇ VE YÖNTEM: Stent içi restenoz saptanmış olan 53 hastanın (yaş:59±5, erkek/kadın: 40/13) klinik özellikleri belirlendi ve balon anjiyoplasti işlemi öncesi, hemen sonrası ve işlemden sonraki 6. ayda ya da klinik endikasyon gelişmişse daha erken dönemde koroner anjiyografileri yapılarak, kantitatif anjiyografik verileri değerlendirildi. Hastaların kardiyovasküler risk faktörleri bulunması ile kantitatif anjiyografik verileri ve 6 aylık klinik izlem sonuçları arasındaki ilişki incelendi. BULGULAR: Sigara içen hastaların %68'inde PTBA sonrası tekrarlayan SİR diffüz darlık şeklinde izlenmiştir (p=0,045). Kadınlardaki minimal lümen çapı ve referans çapları (RÇ), sadece kontrol anjiyografilerindeki ölçümlerde, erkeklere göre daha düşük bulundu (p=0,008). Kontrol koroner anjiyografilerinde ölçülen RÇ'leri, hiperlipidemisi olanlarda, olmayanlara göre daha düşüktü (p=0,050). Rekürren SİR 'in, ailede KAH bulunan hastalarda daha erken ortaya çıktığı gözlendi. (p=0,05, aile öyküsü olanlarda 2,57±2,2 ay, aile öyküsü olmayanlarda 5,57±3,5. ay). Takipleri boyunca ciddi aritmi (p=0,026), reinfarkt gelişen , ölen ve KABG gereksinimi doğan hastaların (p=0,026) tümü hipertansifti. Perkütan balon anjiyoplasti sonrası KABG'ye verilen hastalarda, diğer KAH risk faktörleriyle ilişki saptanmazken, KABG gereksinimi doğan beş hastadan üçü DM idi (p=0,051). Aile öyküsü olanlarda PTBA sonrası Mİ daha sık görüldü (p=0,009) . SONUÇ: Takip sırasındaki klinik olumsuz olaylar ile hastalarda HT, aile öyküsü veya DM bulunması arasında anlamlı ilişki mevcuttur. Sigara içen hastalarda rekürren SİR daha çok diffüz tipte oluşmaktadır. Kadınlarda ve hiperlipidemisi olanlarda başlangıç referans segment de belirgin biçimde etkilenmektedir. Aile öyküsü bulunanlarda SİR'nin PTCA'sı sonrası rekürren stenoz daha erken ortaya çıkmaktadır. Bu sonuçlar; ailede KAH öyküsü bulunanlarda, SİR'nin PTCA sonrası gelişen yanıtın da, daha agresif seyrettiğini, ayrıca stente ve tekrarlanan girişimlere karşı alınan cevapta kalıtsal faktörlerin rolü olabileceğini düşündürmektedir.

🔖

Cite This Article

ARAT, N., BERKALP, B., KERVANCIOĞLU, C. (2002). The effect of coronary artery disease risk factors to development of recurrent in stent restenosis (ISR). MN Kardiyoloji, Cilt: 9 - Sayı: 2, 117–122. https://ajindex.com/articles/299211

References (10)

  1. Schömig A, Kastrati A, Dietz R ve ark. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. J Am Coll Cardiol 1994; 23:1053-60
  2. Holmes DRJ, Vliestra RE, Smith HC ve ark. Restenosis after percutaneous transluminal coroner angioplasty (PTCA): A report from the PTCA registry of the National Heart Lung and Blood Institute. Am J Cardiol. 1984; 53:77C-81C Weintraub WS, Kosinski AS, Brown CL, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21:6-14
  3. Rensing Bj, Hermans WR, Deckers JW ve ark. Which angiographic variable best describes functional status 6 months after succesful single vessel coronary angioplasty? J Am Coll Cardiol. 1993; 21:317-24
  4. Hirsfeld JWJ, Schwartz JS, Jugo R ve ark. Restenosis after coronary angioplasty. A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol. 1991;18:647- 56 Leimgruber PP, Roubin GS, Hollman J ve ark. Restenosis after succesful coronary angioplasty in patients with single vessel disease. Circulation 1986; 73:710-7
  5. Desmarais RL, Sarembock IJ, Ayers CR ve ark. Elevated serum lipoprotein (a) is a risk factor for clinical reccurence after coronary baloon angiplasty. Circulation 1995; 91:1403-9
  6. Black AJ, Anderson HV, Roubin GS ve ark. Repeate coronary angioplasty. Correlates of a second restenosis. J Am Coll Cardiol 1988; 11:714-8
  7. Deligonul U, Vandormael M, Kern MJ, Galan K. Repeate coronary angioplasty for restenosis. Result and predictors of follow-up clinical events. Am Heart J 1989; 117:997-1002 Quigley PJ,Hlatky MA, Hinohara T ce ark. Repeate percutaneous transluminal coronary angioplasty and predictors of reccurent resstenosis. Am C Cardiol 1989; 63:409-13
  8. Sharma S, Duvvuri S, Dangas G, Marmur J, Dailey-Sterling F. Rotational atherectomy for in stent restenosis: acute and long term results of first 100 cases (abst.). Eur Heart J 1997; 18:797 Goods CM, Jain SP, Liu MW, Babu RB, Roubin GS. Intravascular ultrasound guided transluminal atherectomy for restenosis after Gianturco Roubin coronary stent implantation. Cathet Cardiovasc Diagn 1996; 37:317-9
  9. Shiran A, Mintz GS, Waksman R, Mehran R, Abizaid A, ve ark. Early lumen loss after treatment of in-stent restenosis. An intravascular ultrasound study. Circulation 1998; 98:200-3
  10. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ,